Skip to content

Clinical trials

Completed Leukemia, Myeloid, Acute trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Completed Country / region: Netherlands Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20051
20061
20092
20102
20112
20122
20134
20146
20152
20163
20174
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Novartis Pharmaceuticals5
Celgene3
AbbVie2
AstraZeneca2
Daiichi Sankyo2
Gamida Cell ltd2
Radboud University Medical Center2
Astex Pharmaceuticals, Inc.1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute35
Myelodysplastic Syndromes13
Leukemia12
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Recurrence6
Hematologic Neoplasms5
Neoplasms5
Leukemia, Myelomonocytic, Chronic4
Congenital Abnormalities3
Hematologic Diseases3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.